GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
CROMWELL, CT — On a chilly spring morning, local man Jim Harbor reportedly paused to consider whether what he was missing in life was Jesus or a really cool jacket....
The two leaders have indicated that peace with Iran may be imminent, but analysts warn this could be diplomatic maneuvering....
Barr was spotted waiting in the four hour line at a Houston airport on Wednesday...
